Cocrystal Pharma, Inc.
No trades
No trades
Compare with Cocrystal Pharma, Inc.
−0.76 USD
−8.83 M USD
0.00 USD
10.24 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
James E. Sapirstein
Website
Headquarters
Bothell
Founded
2008
IPO date
Mar 12, 2018
ISIN
US19188J4094
CUSIP
19188J409
FIGI
BBG000V27360
Identifiers
ISIN US19188J4094
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.
COCP and playing the setupBuy Shares Strategy -
Buy COCP @ $0.44
RISK 4.7% -> Stop Loss $0.4193
TARGET 1 Reward: +4.7% $0.4607
TARGET 2 Reward: +11.4% $0.4900
Looking to break out of this nice wedge; RSI is looking good, STOCHASTIC is trending neutral however.
8 EMA about to cross the 34 EMA, hoping to catch the move be
$COCPCocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coro
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of COCP is 1.13 USD — it has decreased by −2.59% in the past 24 hours. Watch Cocrystal Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cocrystal Pharma, Inc. stocks are traded under the ticker COCP.
COCP stock has risen by 2.73% compared to the previous week, the month change is a 16.49% rise, over the last year Cocrystal Pharma, Inc. has showed a −23.65% decrease.
We've gathered analysts' opinions on Cocrystal Pharma, Inc. future price: according to them, COCP price has a max estimate of 8.00 USD and a min estimate of 8.00 USD. Watch COCP chart and read a more detailed Cocrystal Pharma, Inc. stock forecast: see what analysts think of Cocrystal Pharma, Inc. and suggest that you do with its stocks.
COCP reached its all-time high on May 20, 2011 with the price of 1,981.98 USD, and its all-time low was 0.76 USD and was reached on Jul 29, 2026. View more price dynamics on COCP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COCP stock is 3.64% volatile and has beta coefficient of 3.01. Track Cocrystal Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cocrystal Pharma, Inc. there?
Yes, you can track Cocrystal Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Cocrystal Pharma, Inc. is going to release the next earnings report on Nov 16, 2026. Keep track of upcoming events with our Earnings Calendar.
COCP earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.17 USD resulting in a −39.39% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about Cocrystal Pharma, Inc. earnings.
Cocrystal Pharma, Inc. revenue for the last quarter amounts to 100.00 K USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
COCP net income for the last quarter is −3.16 M USD, while the quarter before that showed −2.30 M USD of net income which accounts for 0.00% change. Track more Cocrystal Pharma, Inc. financial stats to get the full picture.
No, COCP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 5, 2026, the company has 10 employees. See our rating of the largest employees — is Cocrystal Pharma, Inc. on this list?
Like other stocks, COCP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cocrystal Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cocrystal Pharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cocrystal Pharma, Inc. stock shows the sell signal. See more of Cocrystal Pharma, Inc. technicals for a more comprehensive analysis.









